companydata.dkcompanydata.dk

AKI Therapeutics A/S: Financial statements 2024

CVR: 37509736

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

AKI Therapeutics A/S (CVR 37509736) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -1,960,091 compared with DKK -1,708,694 the year before. Equity in the 2024 report amounted to DKK 806,760. The solvency ratio was 37.2%.

Revenue
DKK 0
Profit/Loss
DKK -1,960,091
Equity
DKK 806,760
Total Assets
DKK 2,168,755

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202400-2M807K-
202300-1.7M747K-
202200-1.1M2.5M-
20210-12K-1.5M3.6M-
2020--89K148K115K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Klaus Poulsen Holding ApS registered as owner of AKI Therapeutics A/SDec 13, 2024

As of December 13, 2024, Klaus Poulsen Holding ApS is registered as an owner of AKI Therapeutics A/S with an ownership share of 5%.

DMZ HOLDING ApS registered as owner of AKI Therapeutics A/SNov 6, 2024

As of November 6, 2024, DMZ HOLDING ApS is registered as an owner of AKI Therapeutics A/S with an ownership share of 15%.

AKI Therapeutics A/S: The 2023 annual report is outJun 18, 2024

AKI Therapeutics A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -1,708,694.

Charlotte Pahl joins the board of AKI Therapeutics A/SJun 13, 2024

As of June 13, 2024, Charlotte Pahl has joined the board of directors of AKI Therapeutics A/S.

About AKI Therapeutics A/S

AKI Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named AKI Therapeutics ApS and Renoguard ApS. The management consists of Sigbjørn Georg Nielsen Kjærgård. The board consists of Charlotte Pahl, Christian Vinding Thomsen and Lars Otto Uttenthal. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,593,852,000 compared with DKK -1,960,091 the year before. Equity in the 2025 report amounted to DKK 551,898,000.

Source: annual report 2025, Danish Business Authority